State Street
IMCR icon

State Street’s Immunocore IMCR Stock Holding History

State Street’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.12M Buy
98,229
+289
+0.3% +$8.55K ﹤0.01% 3193
2026
Q1 		$2.95M Buy
97,940
+4,384
+5% +$142K ﹤0.01% 3174
2025
Q4 		$3.25M Buy
93,556
+2,323
+3% +$82K ﹤0.01% 3171
2025
Q3 		$3.31M Buy
91,233
+9,091
+11% +$309K ﹤0.01% 3158
2025
Q2 		$2.58M Buy
82,142
+983
+1% +$30.5K ﹤0.01% 3219
2025
Q1 		$2.41M Buy
81,159
+3,894
+5% +$117K ﹤0.01% 3173
2024
Q4 		$2.28M Buy
77,265
+594
+0.8% +$18.8K ﹤0.01% 3279
2024
Q3 		$2.39M Buy
76,671
+29,897
+64% +$1.09M ﹤0.01% 3266
2024
Q2 		$1.59M Buy
46,774
+1,328
+3% +$67.7K ﹤0.01% 3389
2024
Q1 		$2.95M Buy
45,446
+1,920
+4% +$132K ﹤0.01% 3139
2023
Q4 		$2.97M Buy
43,526
+1,160
+3% +$60.3K ﹤0.01% 3172
2023
Q3 		$2.2M Buy
42,366
+1,512
+4% +$89.5K ﹤0.01% 3288
2023
Q2 		$2.45M Buy
40,854
+1,688
+4% +$96.3K ﹤0.01% 3316
2023
Q1 		$1.94M Buy
39,166
+2,936
+8% +$165K ﹤0.01% 3352
2022
Q4 		$2.07M Buy
36,230
+27,279
+305% +$1.54M ﹤0.01% 3365
2022
Q3 		$420K Sell
8,951
-2,883
-24% -$137K ﹤0.01% 3842
2022
Q2 		$442K Buy
+11,834
New +$384K ﹤0.01% 3881
2022
Q1 		– Sell
-6,316
Closed -$216K – 4922
2021
Q4 		$216K Buy
6,316
+116
+2% +$4.2K ﹤0.01% 4315
2021
Q3 		$230K Buy
+6,200
New +$209K ﹤0.01% 4304

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

State Street's IMCR Position: Q2 2026 in Review

State Street increased its Immunocore (IMCR) stake by 0.3% in Q2 2026, buying an estimated $8.55K and bringing the position to 98,229 shares worth $3.12M. The position accounts for ﹤0.01% of the portfolio, ranked #3193.

State Street first reported a position in IMCR in Q3 2021 and has held it in 19 quarters since. The position peaked at $3.31M in Q3 2025. 136 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • State Street held 98,229 shares of Immunocore worth $3.12M as of Q2 2026.
  • State Street bought 289 Immunocore shares in Q2 2026, an estimated $8.55K.
  • Immunocore made up ﹤0.01% of State Street's portfolio in Q2 2026, its #3193 holding.
  • State Street first reported a position in Immunocore in Q3 2021 and has held it in 19 quarters since.
  • State Street's Immunocore position peaked at $3.31M in Q3 2025.
  • 136 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.